USPTO 2015–2025 USPTO PatentsView US Corporation

St. Jude Medical, LLC

USPTO PatentsView assignee record - 131 granted patents across 15 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company

The verdict

According to USPTO PatentsView, St. ranks #2,920 of 49,997 tracked US assignees by granted-patent volume, with 131 patents across 15 technology areas.

#2,920
of 49,997 US assignees by volume
Top 24%
by Innovation Score (45.2/100)
17.1
avg claims per patent
-70%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R2920 · US Corporation #2,920 · 131 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MID 131 grants
  • TOP-DECILE #2,920/49,997
  • PHOTO-FINISH Sanford
  • CPC-FOCUS A61F · 15 areas
  • INNOV-PAR 45.2/100
  • CLAIMS-RICH 17.1 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -70% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Sanford L.P. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around St.

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows St.'s Innovation Score is 45.2/100 (top 24% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where St.'s grants concentrate

St. Jude Medical, LLC is a focused PatentsView assignee: 15 CPC subclasses with 77.1% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2017 (26 grants) versus a trough of 3 in 2023. By volume, St. sits between Shenzhen Qianhai Patuoxun Network AND Technology Co., Ltd. and Xiamen University.

St.'s three-year grant acceleration

From 2019–2021 to 2022–2024, St. Jude Medical, LLC moved from 29 to 19 grants (0.66x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,291. See the growth leaderboard.

Who files at St's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows St. holds 131 patents at rank #2,920, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near St

By rank, the assignees closest to #2,920 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in St's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for St, neither rank-band nor same-CPC leaders (those blocks stay above).

St.'s Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

45 Top 24% higher than 76% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0102030 20152016201720182019202020212022202320242025 2
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
St. Jude Medical, LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 17 13.0%
2016 24 18.3%
2017 26 19.8%
2018 14 10.7%
2019 18 13.7%
2020 6 4.6%
2021 5 3.8%
2022 10 7.6%
2023 3 2.3%
2024 6 4.6%
2025partial year 2 1.5%

Which technologies does St. Jude Medical, LLC patent most?

Top 15 of 15 technology areas

Where it ranks

Overall rank by patents

#2,920

of 49,997 tracked assignees

Innovation Score

45.2 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

St. Jude Medical, LLC's patent record in context - here's where to go next.

  • St. Jude Medical, LLC's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 77.1% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #2,920 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare St. Jude Medical, LLC against Shenzhen Qianhai Patuoxun Network AND Technology Co., Ltd., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 45.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.